22:45:19 EDT Wed 08 Jul 2026
Enter Symbol
or Name
USA
CA



Apotex Health Corp
Symbol APTX
Shares Issued 228,499,020
Close 2026-07-08 C$ 38.17
Market Cap C$ 8,721,807,593
Recent Sedar+ Documents

Apotex launches four generic Infuvite products in U.S.

2026-07-08 19:10 ET - News Release

Ms. Christine Baeder reports

APOTEX EXPANDS U.S. HOSPITAL PORTFOLIO WITH LAUNCH OF GENERIC INFUVITE ADULT AND PEDIATRIC INJECTION

Apotex Health Corp. has launched four product configurations of its generic equivalents of Infuvite pediatric injection and Infuvite adult injection in the United States. Of the four configurations launched, the adult bulk and pediatric single presentations received competitive generic therapy exclusivity.

Generic Infuvite adult injection is indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. Generic Infuvite pediatric injection is indicated for the prevention of vitamin deficiency in pediatric patients receiving parenteral nutrition.

The launches further expand Apotex's injectable medicine portfolio and provide health care providers with additional parenteral multivitamin therapy options for pediatric and adult patients across the United States.

Developed in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma Ltd., these products underscore Apotex's commitment to improving access to high-quality medicines and supporting patient care in areas of continuing clinical need.

Together, the launches provide a broad range of parenteral multivitamin options across age groups and help strengthen the availability of essential injectable therapies in the U.S. health care system.

"We remain focused on improving access to medicines that support patients and health care providers every day," said Christine Baeder, president, Apotex USA and LATAM. "The launch of these products reflects our commitment to delivering high-quality, affordable medicines and strengthening our injectable portfolio to help meet evolving health care needs."

About Apotex Inc.

Apotex is the largest Canadian-based pharmaceutical company. It improves everyday access to affordable, innovative medicines and health products for millions of people worldwide through a broad portfolio of generic, biosimilar, specialty and consumer health products. Headquartered in Toronto, with regional offices across the globe, including the United States, Mexico and India, Apotex is a trusted health partner for pharmaceutical licensing, product acquisitions and commercialization throughout the Americas.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.